Dr. Reddy's Faces ₹2,395 Crore Tax Reassessment

  Published 1 year ago

Dr. Reddy's Laboratories is facing a ₹2,395.82 crore tax reassessment notice for AY 2020-21, following its merger with Dr. Reddy's Holding Limited. The company disputes the claim and expects minimal impact.

  • Tax notice issued under Section 148A.
  • Merger approved by NCLT in 2022.
  • Promoters to indemnify against liabilities.

You might like these

Ashok Leyland Posts 4% Sales Growth

Natco Gets US FDA Nod for API Unit

Angel One Sees Client Growth, Turnover Drop

Divi's Stock Upgraded to Buy by HSBC, Targets 7,900 Rupees

BlackRock's 2030 Growth: $35B Revenue, Private Markets Push

IMF Raises India's Growth, Risks Remain

PNC Infratech Wins SECL Mining Contract

News that matters the most ⚡